Literature DB >> 24787976

Clarifying misconceptions about myoblast transplantation in myology.

Daniel Skuk1, Jacques P Tremblay1.   

Abstract

Mesh：

Year:  2014        PMID： 24787976      PMCID： PMC4015228          DOI： 10.1038/mt.2014.57

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  14 in total

1.  Electroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates.

Authors:  Daniel Skuk; Marlyne Goulet; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2013-08       Impact factor: 3.685

Review 2.  In vitro myoblast motility models: investigating migration dynamics for the study of skeletal muscle repair.

Authors:  K P Goetsch; K H Myburgh; Carola U Niesler
Journal:  J Muscle Res Cell Motil       Date:  2013-10-23       Impact factor: 2.698

3.  Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle.

Authors:  Daniel Skuk; Marlyne Goulet; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

4.  Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume.

Authors:  Daniel Skuk; Marlyne Goulet; Jacques P Tremblay
Journal:  Cell Transplant       Date:  2013-01-02       Impact factor: 4.064

5.  Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.

Authors:  Sophie Périé; Capucine Trollet; Vincent Mouly; Valérie Vanneaux; Kamel Mamchaoui; Belaïd Bouazza; Jean Pierre Marolleau; Pascal Laforêt; Françoise Chapon; Bruno Eymard; Gillian Butler-Browne; Jérome Larghero; Jean Lacau St Guily
Journal:  Mol Ther       Date:  2013-07-08       Impact factor: 11.454

Review 6.  Myoblast transplantation for inherited myopathies: a clinical approach.

Authors:  Daniel Skuk
Journal:  Expert Opin Biol Ther       Date:  2004-12       Impact factor: 4.388

7.  Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms.

Authors:  Daniel Skuk; Nicolas J Caron; Marlyne Goulet; Brigitte Roy; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2003-09       Impact factor: 3.685

8.  Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.

Authors:  Daniel Skuk; Brigitte Roy; Marlyne Goulet; Pierre Chapdelaine; Jean-Pierre Bouchard; Raynald Roy; Francine J Dugré; Jean-Guy Lachance; Louise Deschênes; Senay Hélène; Michel Sylvain; Jacques P Tremblay
Journal:  Mol Ther       Date:  2004-03       Impact factor: 11.454

9.  Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source.

Authors:  J R Beauchamp; J E Morgan; C N Pagel; T A Partridge
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

10.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.

Authors:  T A Rando; H M Blau
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539
View more
  10 in total

1.  The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA.

Authors:  Terri J Harford; Greg Kliment; Girish C Shukla; Crystal M Weyman
Journal:  Apoptosis       Date:  2017-12       Impact factor: 4.677

Review 2.  Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.

Authors:  Francesco Saverio Tedesco
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

Review 3.  Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle.

Authors:  Olivier Boyer; Gillian Butler-Browne; Hector Chinoy; Giulio Cossu; Francesco Galli; James B Lilleker; Alessandro Magli; Vincent Mouly; Rita C R Perlingeiro; Stefano C Previtali; Maurilio Sampaolesi; Hubert Smeets; Verena Schoewel-Wolf; Simone Spuler; Yvan Torrente; Florence Van Tienen
Journal:  Front Genet       Date:  2021-08-02       Impact factor: 4.599

4.  Human myogenic reserve cells are quiescent stem cells that contribute to muscle regeneration after intramuscular transplantation in immunodeficient mice.

Authors:  Thomas Laumonier; Flavien Bermont; Pierre Hoffmeyer; Vincent Kindler; Jacques Menetrey
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

5.  CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.

Authors:  Seraina A Domenig; Nicola Bundschuh; Ajda Lenardič; Adhideb Ghosh; Inseon Kim; Xhem Qabrati; Gommaar D'Hulst; Ori Bar-Nur
Journal:  Stem Cell Reports       Date:  2022-01-06       Impact factor: 7.294

Review 6.  Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.

Authors:  Serge Ostrovidov; Xuetao Shi; Ramin Banan Sadeghian; Sahar Salehi; Toshinori Fujie; Hojae Bae; Murugan Ramalingam; Ali Khademhosseini
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 6.692

7.  The Process of Engraftment of Myogenic Cells in Skeletal Muscles of Primates: Understanding Clinical Observations and Setting Directions in Cell Transplantation Research.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

Review 8.  Centronuclear myopathies under attack: A plethora of therapeutic targets.

Authors:  Hichem Tasfaout; Belinda S Cowling; Jocelyn Laporte
Journal:  J Neuromuscul Dis       Date:  2018

9.  Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method.

Authors:  Jean-Paul Iyombe-Engembe; Dominique L Ouellet; Xavier Barbeau; Joël Rousseau; Pierre Chapdelaine; Patrick Lagüe; Jacques P Tremblay
Journal:  Mol Ther Nucleic Acids       Date:  2016-01-26       Impact factor: 10.183

10.  Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.

Authors:  Sara Benedetti; Narumi Uno; Hidetoshi Hoshiya; Martina Ragazzi; Giulia Ferrari; Yasuhiro Kazuki; Louise Anne Moyle; Rossana Tonlorenzi; Angelo Lombardo; Soraya Chaouch; Vincent Mouly; Marc Moore; Linda Popplewell; Kanako Kazuki; Motonobu Katoh; Luigi Naldini; George Dickson; Graziella Messina; Mitsuo Oshimura; Giulio Cossu; Francesco Saverio Tedesco
Journal:  EMBO Mol Med       Date:  2018-02       Impact factor: 12.137
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.